Prophylactic efficacy and tolerance of low-dose intranasal interferon-alpha2 in natural respiratory viral infections
- 1 April 1985
- journal article
- research article
- Published by Elsevier BV in Antiviral Research
- Vol. 5 (2), 111-116
- https://doi.org/10.1016/0166-3542(85)90037-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Intranasal interferon-alpha 2 for prevention of natural rhinovirus coldsAntimicrobial Agents and Chemotherapy, 1984
- INTRANASAL INTERFERON FOR CONTACT PROPHYLAXIS AGAINST COMMON COLD IN FAMILIESThe Lancet, 1983
- Intranasal Interferon 2 for Prevention of Rhinovirus Infection and IllnessThe Journal of Infectious Diseases, 1983
- Efficacy and Tolerance of Intranasally Applied Recombinant Leukocyte A Interferon in Normal VolunteersThe Journal of Infectious Diseases, 1983
- Anti-interferon antibody increases rhinovirus isolation rates from nasal wash specimens containing interferon-alpha2Antiviral Research, 1983
- PREVENTION OF RHINOVIRUS COLDS BY HUMAN INTERFERON ALPHA-2 FROM ESCHERICHIA COLIThe Lancet, 1982
- Purified interferon as protection against rhinovirus infection.BMJ, 1982
- Prophylactic Effect of Low Doses of Human Leukocyte Interferon Against Infection with RhinovirusThe Journal of Infectious Diseases, 1982
- Rhinovirus Infections in an Industrial PopulationNew England Journal of Medicine, 1966